Champions Oncology, Inc. (CSBR)
4.99
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 16:00
4.99
0.00 (0.00%)
After-Hours: 20:00
Champions Oncology Cash from Operations (TTM) : -4.472M for April 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| April 30, 2026 | -4.472M |
| January 31, 2026 | 4.394M |
| October 31, 2025 | 6.223M |
| July 31, 2025 | 7.675M |
| April 30, 2025 | 7.386M |
| January 31, 2025 | -1.298M |
| October 31, 2024 | -2.707M |
| July 31, 2024 | -1.835M |
| April 30, 2024 | -6.137M |
| January 31, 2024 | -5.013M |
| October 31, 2023 | -2.521M |
| July 31, 2023 | 0.176M |
| April 30, 2023 | 3.972M |
| January 31, 2023 | 5.46M |
| October 31, 2022 | 8.144M |
| July 31, 2022 | 6.086M |
| April 30, 2022 | 6.497M |
| January 31, 2022 | 3.721M |
| October 31, 2021 | -0.401M |
| July 31, 2021 | -0.75M |
| April 30, 2021 | -1.681M |
| January 31, 2021 | 2.844M |
| October 31, 2020 | 2.988M |
| July 31, 2020 | 2.469M |
| April 30, 2020 | 2.905M |
| Date | Value |
|---|---|
| January 31, 2020 | 0.612M |
| October 31, 2019 | 1.543M |
| July 31, 2019 | 1.247M |
| April 30, 2019 | 1.862M |
| January 31, 2019 | 1.619M |
| October 31, 2018 | 0.854M |
| July 31, 2018 | 1.058M |
| April 30, 2018 | -1.226M |
| January 31, 2018 | -0.837M |
| October 31, 2017 | -1.965M |
| July 31, 2017 | -2.334M |
| April 30, 2017 | -2.84M |
| January 31, 2017 | -3.837M |
| October 31, 2016 | -3.88M |
| July 31, 2016 | -6.376M |
| April 30, 2016 | -6.465M |
| January 31, 2016 | -7.874M |
| October 31, 2015 | -9.524M |
| July 31, 2015 | -9.387M |
| April 30, 2015 | -9.632M |
| January 31, 2015 | -7.526M |
| October 31, 2014 | -6.806M |
| July 31, 2014 | -4.104M |
| April 30, 2014 | -3.46M |
| January 31, 2014 | -4.718M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Medpace Holdings, Inc. | 752.66M |
| Avantor, Inc. | 597.00M |
| Personalis, Inc. | -92.30M |
| Adaptive Biotechnologies Corp. | -21.01M |
| 10X Genomics, Inc. | 127.08M |